DEVICE ISSUE: NONE. ADVERSE EVENT: THROMBOSIS REQUIRING INTERVENTION. IT WAS REPORTED VIA TRIAL THAT ON (B) (6) 2009, THE PATIENT UNDERWENT DIRECT STENTING IN THE 1ST OBTUSE MARGINAL (OM) WITH ONE XIENCE V STENT AND IN THE PREDILATED PROXIMAL CIRCUMFLEX ARTERY WITH ONE XIENCE V STENT. ON (B) (6) 2010, THE PATIENT EXPERIENCED LEFT SHOULDER PAIN FOR ONE WEEK AND WAS ADMITTED TO THE HOSPITAL ON (B) (6) 2010, WHERE A DIAGNOSTIC CORONARY ANGIOGRAPHY REVEALED 95% STENT THROMBOSIS IN THE OM THAT REQUIRED REVASCULARIZATION VIA ANGIOPLASTY ONLY. PERCUTANEOUS REVASCULARIZATION WAS PERFORMED ON (B) (6) 2010, OF THE OM TARGET LESION AND THE PATIENT'S SYMPTOMS RESOLVED SAME DAY. THERE WAS NO ADVERSE PATIENT SEQUELA. THE PATIENT WAS DISCHARGED ON (B) (6) 2010. THE PATIENT'S CLOPIDOGREL WAS CHANGED TO PRASUGREL ON (B) (6) 2010. NO ADDITIONAL INFORMATION WAS PROVIDED.
